Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status
Citations Over TimeTop 1% of 2014 papers
Abstract
Obesity is associated with a cluster of metabolic disorders, low-grade inflammation and altered gut microbiota. Whether host metabolism is controlled by intestinal innate immune system and the gut microbiota is unknown. Here we report that inducible intestinal epithelial cell-specific deletion of MyD88 partially protects against diet-induced obesity, diabetes and inflammation. This is associated with increased energy expenditure, an improved glucose homeostasis, reduced hepatic steatosis, fat mass and inflammation. Protection is transferred following gut microbiota transplantation to germ-free recipients. We also demonstrate that intestinal epithelial MyD88 deletion increases anti-inflammatory endocannabinoids, restores antimicrobial peptides production and increases intestinal regulatory T cells during diet-induced obesity. Targeting MyD88 after the onset of obesity reduces fat mass and inflammation. Our work thus identifies intestinal epithelial MyD88 as a sensor changing host metabolism according to the nutritional status and we show that targeting intestinal epithelial MyD88 constitutes a putative therapeutic target for obesity and related disorders.
Related Papers
- → Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats(2017)148 cited
- → Wired on sugar: the role of the CNS in the regulation of glucose homeostasis(2012)118 cited
- → Role of probiotics in modulating glucose homeostasis: evidence from animal and human studies(2013)26 cited
- → Hypothalamic Proopiomelanocortin Is Necessary for Normal Glucose Homeostasis in Female Mice(2018)9 cited
- Central Nervous System Nutrient-sensing and the Regulation of Energy and Glucose Homeostasis(2010)